Cargando…

A LEX Friedrich

Detalles Bibliográficos
Autor principal: Kiers, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445253/
https://www.ncbi.nlm.nih.gov/pubmed/34548841
http://dx.doi.org/10.1007/s41187-021-1073-z
_version_ 1784568611447242752
author Kiers, Bart
author_facet Kiers, Bart
author_sort Kiers, Bart
collection PubMed
description
format Online
Article
Text
id pubmed-8445253
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Bohn Stafleu van Loghum
record_format MEDLINE/PubMed
spelling pubmed-84452532021-09-17 A LEX Friedrich Kiers, Bart Zorgvisie Interview Bohn Stafleu van Loghum 2021-09-24 2021 /pmc/articles/PMC8445253/ /pubmed/34548841 http://dx.doi.org/10.1007/s41187-021-1073-z Text en © Bohn Stafleu van Loghum is een imprint van Springer Media B.V., onderdeel van Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Interview
Kiers, Bart
A LEX Friedrich
title A LEX Friedrich
title_full A LEX Friedrich
title_fullStr A LEX Friedrich
title_full_unstemmed A LEX Friedrich
title_short A LEX Friedrich
title_sort lex friedrich
topic Interview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445253/
https://www.ncbi.nlm.nih.gov/pubmed/34548841
http://dx.doi.org/10.1007/s41187-021-1073-z
work_keys_str_mv AT kiersbart alexfriedrich
AT kiersbart lexfriedrich